Skip to content

Clinical trials

Sarcoma, Ewing trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma, Ewing Country / region: Australia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20171
20191
20202
20212
20221
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting6
Completed3
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
Eli Lilly and Company2
3B Pharmaceuticals GmbH1
Amgen1
Bristol-Myers Squibb1
Cellectar Biosciences, Inc.1
Children's Oncology Group1
Gustave Roussy, Cancer Campus, Grand Paris1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma, Ewing13
Neuroblastoma8
Rhabdomyosarcoma7
Ependymoma6
Glioma6
Medulloblastoma6
Osteosarcoma6
Wilms Tumor6
Lymphoma, Non-Hodgkin5
Rhabdoid Tumor5

Trials

Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.